Peptipedia
BioregulatorPreclinicalAnimal Studies

Crystagen

Also known as Glu-Asp-Pro, EDP

A tripeptide bioregulator supporting immune system function. Demonstrates age-associated immunoprotective properties in spleen tissue.

Preclinical research, approved in Russia as supplement
CompareFind Vendors

Regulatory Pathway

Preclinical
Phase I
Phase II
Phase III
Phase IV
Approved

Dosing Protocol

Typical Dose

10-20 mg daily

Frequency

Once or twice daily

Duration

10-30 day cycles

Community-reported dosing. Individual results vary. Not a medical recommendation.
Typical community protocol: 10-20 mg daily via Oral capsules or sublingual, Once or twice daily. Dose range: 10-20 mg daily. Duration: 10-30 day cycles.

Timing & Administration

Administer via Oral capsules or sublingual. Frequency: Once or twice daily.

Mechanism of Action

Modulates immune cell function and gene expression patterns. Maintains healthy immune response during aging, particularly in splenic tissue.

Research Summary

Evidence level: animal studies. Clinical status: Preclinical research, approved in Russia as supplement.

Side Effects & Safety

Important Warnings

  • Not FDA approved
Generally well-tolerated
limited safety data outside Russia

References

No references available.

Related Peptides

Browse all →
EpithalonBioregulator

A tetrapeptide studied for its effects on telomerase activation and potential anti-aging properties.

View profile
ThymalinBioregulator

A thymic peptide complex utilized in Russia for immune enhancement and longevity support, developed through Professor Khavinson's bioregulator peptide research.

View profile
VilonBioregulator

A synthetic dipeptide bioregulator targeting thymic function. Part of Khavinson's peptide bioregulator research for immune and anti-aging effects.

View profile